Funded Startups in Hangzhou
Hangzhou entries shown span 2025-09-12 to 2025-11-29 (29 rows), with the most recent round at Caterpillar Valves (Series A) on 2025-11-29 for $7M.
Hangzhou entries shown span 2025-09-12 to 2025-11-29 (29 rows), with the most recent round at Caterpillar Valves (Series A) on 2025-11-29 for $7M. Disclosed deal sizes cluster heavily around $14M, with multiple $14M rounds (e.g., Vybio $14M on 2025-11-10; Platinum Electronics $14M on 2025-11-03; Surron $14M on 2025-09-26; Jing'an Technology $14M on 2025-09-23) while a single outlier sits well above the rest: Reprogenix raised $70M on 2025-11-19, and Kind Pharmaceutical follows at $56M on 2025-11-13.
Sector and stage signals skew toward biotech and structured financing labels rather than undisclosed amounts: 7 of 29 rows are explicitly in biotech/pharma-related categories (e.g., Healzen Therapeutics on 2025-11-25; Healsun Biopharm on 2025-11-21; Reprogenix on 2025-11-19; Kind Pharmaceutical on 2025-11-13; Polymed Biopharmaceuticals on 2025-10-27; Gaowei Medicine on 2025-11-16; Vybio on 2025-11-10). Stage mix shows many undisclosed amounts (12 of 29 rows), including “Venture - Series Unknown” appearing 3 times (Hyperspectral Imaging 2025-10-18; Null Hypothesis 2025-11-01; Ganzhicao Technology 2025-09-17).
Most recent rounds
29 shownRelated listings
Frequently asked
Which disclosed round size is the standout outlier in these Hangzhou entries?
Reprogenix’s $70M Series A on 2025-11-19 is the only disclosed amount above $50M, followed by Kind Pharmaceutical’s $56M on 2025-11-13; the rest of the disclosed figures largely sit at $28M, $14M, or $7M (e.g., Liongo $28M on 2025-11-16; Caterpillar Valves $7M on 2025-11-29).
How concentrated are disclosed deal sizes, and what does the $14M pattern suggest?
Several disclosed rounds land on $14M: Vybio ($14M on 2025-11-10), Platinum Electronics ($14M on 2025-11-03), Surron ($14M on 2025-09-26), and Jing'an Technology ($14M on 2025-09-23). That repetition contrasts with fewer larger disclosures like Liongo’s $28M (2025-11-16) and the outlier pair at $56M and $70M.
Are rounds clustered in a narrow time window near the most recent dates?
Yes. The list covers 2025-09-12 through 2025-11-29, and many entries fall in October–November, including back-to-back same-day submissions like 2025-11-25 (Healzen Therapeutics and Zhongneng Optoelectronics Technology, both undisclosed).
What does the stage and amount-label mix look like (Series labels vs undisclosed vs “Series Unknown”)?
Undisclosed amounts appear in 12 of 29 rows (e.g., Healzen Therapeutics on 2025-11-25; Healsun Biopharm on 2025-11-21; Longxing Avionics on 2025-11-01). “Venture - Series Unknown” shows up 3 times (Hyperspectral Imaging on 2025-10-18; Null Hypothesis on 2025-11-01; Ganzhicao Technology on 2025-09-17), while other rounds use explicit labels like Series A/B/C (e.g., Caterpillar Valves Series A; Reprogenix Series A; Kind Pharmaceutical Series C).
Which sectors are most represented, and is any sector tied to the largest disclosed rounds?
Biotech/pharma-related categories are the most common at 7 of 29 rows (including Reprogenix, Kind Pharmaceutical, Healsun Biopharm, and Gaowei Medicine). Both of the largest disclosed rounds by amount—Reprogenix at $70M (2025-11-19) and Kind Pharmaceutical at $56M (2025-11-13)—fall within this biotech/pharma cluster.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.